Nucleic Acids Research, 2003, Vol. 31, No. 17 5033-5038
© 2003 Oxford University Press
Promoter choice affects the potency of HIV-1 specific RNA interference
Laboratory of Retrovirology, Division of Infectious Diseases, Department of Medicine, Brown Medical School, 4th floor, 55 Claverick Street, Providence, RI 02903, USA
*To whom correspondence should be addressed. Tel: +1 401 444 5219; Fax: +1 401 444 2939; Email: BRamratnam{at}Lifespan.org
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
RNA interference (RNAi) is mediated by small interfering (si) RNAs that target and degrade mRNA in a sequence-specific manner. Cellular expression of siRNA can be achieved by the use of expression cassettes driven by RNA polymerase III (pol III) promoters. Here, we demonstrate that a modified tRNAmet-derived (MTD) promoter effectively drives the cellular expression of HIV-1-specific siRNA. We observed up to 56% greater inhibition of virus production when the MTD promoter was used to drive the expression of short hairpin (sh) RNA targeting the HIV-1 transactivator protein tat compared to cassettes containing other pol III promoters such as H1, U6+1 and U6+27. We conclude that the MTD promoter is ideally suited to drive intracellular expression of HIV-1 specific siRNA and may serve as an important component of future RNAi vector delivery systems.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. M. Ghahramani Seno, I. R. Graham, T. Athanasopoulos, C. Trollet, M. Pohlschmidt, M. R. Crompton, and G. Dickson RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology Hum. Mol. Genet., September 1, 2008; 17(17): 2622 - 2632. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hassani, J.-C. Francois, G. Alfama, G. M. Dubois, M. Paris, C. Giovannangeli, and B. A. Demeneix A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain Nucleic Acids Res., May 14, 2007; 35(9): e65 - e65. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Brenz Verca, P. Weber, C. Mayer, C. Graf, D. Refojo, R. Kuhn, I. Grummt, and B. Lutz Development of a species-specific RNA polymerase I-based shRNA expression vector Nucleic Acids Res., January 28, 2007; 35(2): e10 - e10. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishitsuji, M. Kohara, M. Kannagi, and T. Masuda Effective Suppression of Human Immunodeficiency Virus Type 1 through a Combination of Short- or Long-Hairpin RNAs Targeting Essential Sequences for Retroviral Integration. J. Virol., August 1, 2006; 80(15): 7658 - 7666. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Singer, A. Yanai, and I. M. Verma Silence of the genes PNAS, April 13, 2004; 101(15): 5313 - 5314. [Full Text] [PDF] |
||||
![]() |
D. Boden, O. Pusch, R. Silbermann, F. Lee, L. Tucker, and B. Ramratnam Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins Nucleic Acids Res., February 13, 2004; 32(3): 1154 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pusch, D. Boden, R. Silbermann, F. Lee, L. Tucker, and B. Ramratnam Nucleotide sequence homology requirements of HIV-1-specific short hairpin RNA Nucleic Acids Res., November 15, 2003; 31(22): 6444 - 6449. [Abstract] [Full Text] [PDF] |
||||



